FDA Approves Treatment for Children With Allergic Rhinitis
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) announced today that the U.S. Food and Drug Administration (FDA) approved QNASL® (beclomethasone dipropionate) 40 mcg for the treatment of nasal symptoms associated with allergic rhinitis (AR) in children 4-11 years of age.
The Geography of Hay Fever
Red, running noses and watery eyes are all too common for those living with hay fever allergies. But kids in some states may deal with hay fever more than others.
Allergy Drops Not Shots for Tots
Bringing a child to the doctor to get allergy shots can be a traumatic experience for both the child and the caretaker. A new treatment might offer an alternative to the dreaded needles.
Managing Asthma Can Reduce ER Trips
When teaching children fire drills, the mantra is STOP, DROP, and ROLL. When teaching asthma attack prevention, a new mantra of MANAGE, ANTICIPATE, and AVOID is in order.